MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/15/1006/001 
Respreeza 
1000 mg 
EU/1/15/1006/002 
Respreeza 
4000 mg 
EU/1/15/1006/003 
Respreeza 
5000 mg 
Powder and 
solvent for 
solution for 
infusion 
Powder and 
solvent for 
solution for 
infusion 
Powder and 
solvent for 
solution for 
infusion 
Intravenous use 
Intravenous use 
Intravenous use 
Powder: vial 
(glass) 
Solvent: vial 
(glass) 
Powder: vial 
(glass) 
Solvent: vial 
(glass) 
Powder: vial 
(glass) 
Solvent: vial 
(glass) 
Powder: 1000 mg 
Solvent: 20 ml 
1 vial + 1 vial + 1 
transfer set 20/20 
(Mix2Vial set) 
Powder: 4000 mg 
Solvent: 76 ml 
1 vial + 1 vial + 1 
transfer set 20/20 
(Mix2Vial set) 
Powder: 5000 mg 
Solvent: 95 ml 
1 vial + 1 vial + 1 
transfer set 20/20 
(Mix2Vial set) 
1/1 
 
 
 
 
 
 
